News
Knowledge agenda sets goals
January 31, 2012 - Minister of Health, Welfare and Sport Edith Schippers has sent the 'knowledge agenda' (kennisagenda) to parliament.
Biogen Idec Surpasses $5 Billion in 2011 Annual Revenue
January 31, 2012 - Biogen Idec, a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its full year and fourth quarter 2011 results.
Cortical Studios wins international film awards
January 31, 2012 - "Our Immune System" is an award-winning movie commissioned by Pfizer BV, that shows the complexity of inflammation and autoimmune diseases.
European Commission Delays Decision on Glybera Marketing Authorisation
January 30, 2012 – Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, was informed on Friday January 27, 2012 after business hours that the European Commission’s Standing Committee discussed on Monday January 22, 2012 the implementation decision not to grant marketing authorization for Glybera (alipogene tiparvovec) as recommended by the Committee for Human Medicinal Products (CHMP).
Fornix publishes preliminary results over 2011
January 26, 2012 - Net profit is € 150.000 (2010: € 13,6 million).
Avantium and Rhodia to jointly develop biobased polyamides
January, 24, 2012 – Rhodia, member of the Solvay Group, and Avantium announced today that they have entered into a partnership to jointly develop a range of new bio-based polyamides targeting a variety of applications.
Dutch biotech company profiles updated for BIO-Europe Spring
January 20, 2012 - LSH will provide an update of the PDF of the Life Sciences Health company profile book before BIO-Europe Spring, the next big event for biotech companies to partner and network.
International companies come to Amsterdam
January 19, 2012 - In 2011, a total of 118 new international companies established offices in the Amsterdam Metropolitan Area.
Life Sciences featured on RTL news
January 19, 2012 - After publication of the Life Sciences Outlook 2012, RTL reported on the success of the Dutch biotech industry.
VUmc: supplemental oxygen not always good
January 11, 2012 - In medical emergencies, such as acute coronary syndrome, cardiopulmonary resuscitation (CPR), stroke, and exacerbations of chronic obstructive pulmonary disease (COPD), supplemental oxygen is often routinely administered.
Peter C. Wulff VP of Finance and CFO Agendia
January 9, 2012 – Agendia today announced that Peter C. Wulff has joined the company as Vice President of Finance and Chief Financial Officer.
Agendia Signs Contract with Blue Shield of California
January 5, 2012 – Agendia, an innovative molecular cancer diagnostics company, has signed a contract with Blue Shield of California, making Agendia an in-network provider.
